Back to Trades
Hively Brad
DirectorCIK 0001891124
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025–2026
Hively Brad, Director, has filed 4 SEC reports (2025–2026), all concentrated in Starling Oncology, Inc. (STLN), totaling $2.0M in disclosed volume. Weighing $0 bought versus $2.0M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Aug 24 | STLN Starling Oncology, Inc. | Hively Brad | Director | Sell | $1.9M |
| Jul 29 | TOI Oncology Institute, Inc. | Hively Brad | Director | Grant | $0 |
| Nov 24 | TOI Oncology Institute, Inc. | Hively Brad | Director | Grant | $0 |
| Aug 21 | TOI Oncology Institute, Inc. | Hively Brad | Director | Sell | $82.1K |
4 filings